Chamanlal Setia Exports Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/efu3hd79r9v91fuo1briuetv.pdf

Key Takeaways


The Product Pipeline: R&D as Competitive Moat

Vijay Setia: "This will be something very interesting that the new developments which we are doing in the company, they will give our company a very bright future and a different place in the industry."

Brand & Product Mix: The Margin Story

Vijay Setia: "You see, you have to think out of box. You have to do some differently, otherwise for common man rice and rice and his questions are always that why you are making more profits."

Export Business & Customer Base

Vijay Setia: "I can say we were lucky. I won't say that we are best judge, no, it is sheer luck also that we were in that position at that time."

Raw Material & Cost Outlook


Domestic Market & New Categories

Vijay Setia: "if you are kicking rice against rice, it's a fight. And if you have a product against rice, you have an edge."

Capital Allocation & Social Initiatives

Vijay Setia: "I will prefer that from our CSR fund that we should go ahead with this project if we can help our country with this type of alternative for the pesticides, I think it is the best investment than anything else I'm doing in my life."

Guidance & Commitments

CommitmentSpecificsTimeline
Dry heat rice relaunchLaunch under Maharani brand across all world marketsComing season
2-minute rice productionDedicated production line being set up; patent being filedNo date (line being set up)
Organic pesticide substitute trialsPaddy trials at HAUThis season
IARI ring trials funding₹25-50 lakhs from CSR fund for pesticide-alternative validationNo date (management preference stated)
Vitamin D rice launchLaunch "at a right time, at a right price"No date (cost reduction work ongoing)
Japan business revivalSankesh Setia meeting 2-3 companies in JapanImminent (travel in three days from call)
Domestic value-added product launchMarketing spend and launch once products are in "fine shape"No date (production readiness-dependent)

Key Metrics

MetricQ4 FY23
Revenue (FY23 full year)₹1,387 cr, up 49% YoY from ₹932 cr
Sales volume growth (FY23 full year)28% YoY
Operating margin (Q4 FY23)~14% (per an analyst's math)
EBITDA (past two quarters run-rate)~₹50 cr per quarter (per an analyst's math)
EBITDA margin (FY23 full year)11.5%, up from 10.2% in FY22 (per an analyst's math)
Q4 sales volume41,000 metric tons, vs 53,000 metric tons in Q4 FY22 (per an analyst's math)
Basmati export value$1,000 to $1,300–1,400 per ton starting variant price
Indian basmati exports growth (FY23)14%
Maharani brand share of total sales~10%–12%
Rice suitable for diabetics share of exports7–8%
Exports as share of total rice salesMore than 90%
Number of export countriesMore than 90
Number of global customers~400
Dividend recommended₹1 per share (50%)